Jockeying over patents is driving investment and competition among the growing number of people and companies trying to profit from the psychedelics renaissance. Graham Pechenik is one of the smartest and most respected attorneys specializing in this area. We started off by discussing a recent victory against the DEA, which had tried to put a number of promising compounds into Schedule I. Most of our conversation thereafter focused on current battles among investors, activists and researchers, the challenges of trying to reform a patent system that is widely seen as flawed and even broken, and alternative paths for maximizing the benefits and accessibility of psychedelic medicine.
See omnystudio.com/listener for privacy information.
Steve Rolles on Legalizing Drugs
Charley & Shelley Wininger On Healthy Aging & Sex with MDMA
Paul Gootenberg on the Global History of Drugs
Dennis McKenna on The Brotherhood of the Screaming Abyss
Neil Carrier on Khat
Bonus episode: Psychedelic Confessions - Speaking Personally
Lisa McGirr on Alcohol Prohibition and the Rise of the American State
Gabor Maté on Trauma and the Myth of Normal
Chris Kilham - "The Medicine Hunter" - on Kava
Ellen Scanlon on Women & Cannabis
Bonus Episode: How to Do the Pot
Hattie Wells on Ibogaine Treatment
Martin Lee on CBD: It's a Molecule, Not a Miracle
Chelsea Handler on Drugs
Lynn Paltrow on Pregnancy and Drugs
Martin Torgoff on Jazz, Race, The Beats & Drugs
Kurt Schmoke: Profile in Courage
Boris Jordan on the Politics & Future of the Cannabis Industry
Edward Slingerland on Intoxication & Civilization
Create your
podcast in
minutes
It is Free
The Modern West
Just Dumb Enough Podcast
Voices of Misery Podcast
House of Whimsical Terror
Stuff You Should Know
Timcast IRL